JETBLUE AIRWAYS CORP (JBLU) Fundamental Analysis & Valuation

NASDAQ:JBLU • US4771431016

Current stock price

4.215 USD
-0.29 (-6.54%)
Last:

This JBLU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. JBLU Profitability Analysis

1.1 Basic Checks

  • In the past year JBLU has reported negative net income.
  • In the past year JBLU has reported a negative cash flow from operations.
  • JBLU had negative earnings in each of the past 5 years.
  • Of the past 5 years JBLU 4 years had a positive operating cash flow.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • JBLU has a Return On Assets of -3.63%. This is in the lower half of the industry: JBLU underperforms 63.64% of its industry peers.
  • Looking at the Return On Equity, with a value of -28.40%, JBLU is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
ROA -3.63%
ROE -28.4%
ROIC N/A
ROA(3y)-3.53%
ROA(5y)-2.94%
ROE(3y)-22.6%
ROE(5y)-16.54%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • JBLU has a better Gross Margin (69.22%) than 90.91% of its industry peers.
  • In the last couple of years the Gross Margin of JBLU has grown nicely.
  • JBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.52%
GM growth 5Y1.68%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. JBLU Health Analysis

2.1 Basic Checks

  • JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • JBLU has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for JBLU has been increased compared to 5 years ago.
  • The debt/assets ratio for JBLU is higher compared to a year ago.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that JBLU is in the distress zone and has some risk of bankruptcy.
  • JBLU has a Altman-Z score (0.53) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 3.65 is on the high side and indicates that JBLU has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 3.65, JBLU is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.65
Debt/FCF N/A
Altman-Z 0.53
ROIC/WACCN/A
WACC5.92%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 0.74 indicates that JBLU may have some problems paying its short term obligations.
  • The Current ratio of JBLU (0.74) is better than 72.73% of its industry peers.
  • JBLU has a Quick Ratio of 0.74. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.69, JBLU is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.69
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. JBLU Growth Analysis

3.1 Past

  • The earnings per share for JBLU have decreased strongly by -127.78% in the last year.
  • The Revenue has decreased by -2.34% in the past year.
  • Measured over the past years, JBLU shows a very strong growth in Revenue. The Revenue has been growing by 25.10% on average per year.
EPS 1Y (TTM)-127.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-0.35%
Revenue growth 5Y25.1%
Sales Q2Q%-1.45%

3.2 Future

  • JBLU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.46% yearly.
  • The Revenue is expected to grow by 7.24% on average over the next years.
EPS Next Y41.08%
EPS Next 2Y35.57%
EPS Next 3Y26.46%
EPS Next 5YN/A
Revenue Next Year8.57%
Revenue Next 2Y7.91%
Revenue Next 3Y7.24%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. JBLU Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for JBLU. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • JBLU's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.27
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as JBLU's earnings are expected to grow with 26.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.57%
EPS Next 3Y26.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. JBLU Dividend Analysis

5.1 Amount

  • JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

JBLU Fundamentals: All Metrics, Ratios and Statistics

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (3/27/2026, 2:40:08 PM)

4.215

-0.29 (-6.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)01-27
Earnings (Next)04-27
Inst Owners75.03%
Inst Owner Change8.87%
Ins Owners9.94%
Ins Owner Change13.4%
Market Cap1.56B
Revenue(TTM)9.06B
Net Income(TTM)-602.00M
Analysts49.57
Price Target4.87 (15.54%)
Short Float %19.97%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.75%
Min EPS beat(2)-6.21%
Max EPS beat(2)11.7%
EPS beat(4)3
Avg EPS beat(4)16.02%
Min EPS beat(4)-6.21%
Max EPS beat(4)52.85%
EPS beat(8)7
Avg EPS beat(8)40.48%
EPS beat(12)9
Avg EPS beat(12)26.4%
EPS beat(16)11
Avg EPS beat(16)0.28%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-1.69%
Max Revenue beat(2)-1.1%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.12%
Revenue beat(8)1
Avg Revenue beat(8)-1.04%
Revenue beat(12)1
Avg Revenue beat(12)-1.26%
Revenue beat(16)1
Avg Revenue beat(16)-1.46%
PT rev (1m)3.33%
PT rev (3m)10.47%
EPS NQ rev (1m)-2.65%
EPS NQ rev (3m)-5.39%
EPS NY rev (1m)3.88%
EPS NY rev (3m)10.61%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.91
EV/EBITDA 22.27
EPS(TTM)-1.64
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-3.29
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS24.48
BVpS5.73
TBVpS4.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.63%
ROE -28.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.22%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.94%
ROE(3y)-22.6%
ROE(5y)-16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.52%
GM growth 5Y1.68%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 3.65
Debt/FCF N/A
Debt/EBITDA 22.08
Cap/Depr 163.08%
Cap/Sales 12.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.69
Altman-Z 0.53
F-Score4
WACC5.92%
ROIC/WACCN/A
Cap/Depr(3y)201.49%
Cap/Depr(5y)189.3%
Cap/Sales(3y)14.12%
Cap/Sales(5y)13.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y41.08%
EPS Next 2Y35.57%
EPS Next 3Y26.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-0.35%
Revenue growth 5Y25.1%
Sales Q2Q%-1.45%
Revenue Next Year8.57%
Revenue Next 2Y7.91%
Revenue Next 3Y7.24%
Revenue Next 5YN/A
EBIT growth 1Y-263.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year291.57%
EBIT Next 3Y75.31%
EBIT Next 5YN/A
FCF growth 1Y17.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-165.28%
OCF growth 3YN/A
OCF growth 5YN/A

JETBLUE AIRWAYS CORP / JBLU Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JETBLUE AIRWAYS CORP?

ChartMill assigns a fundamental rating of 2 / 10 to JBLU.


Can you provide the valuation status for JETBLUE AIRWAYS CORP?

ChartMill assigns a valuation rating of 1 / 10 to JETBLUE AIRWAYS CORP (JBLU). This can be considered as Overvalued.


How profitable is JETBLUE AIRWAYS CORP (JBLU) stock?

JETBLUE AIRWAYS CORP (JBLU) has a profitability rating of 2 / 10.


How financially healthy is JETBLUE AIRWAYS CORP?

The financial health rating of JETBLUE AIRWAYS CORP (JBLU) is 1 / 10.